Literature DB >> 24704909

Simultaneous UPLC-MS/MS analysis of native catechins and procyanidins and their microbial metabolites in intestinal contents and tissues of male Wistar Furth inbred rats.

Katheryn M Goodrich1, Andrew P Neilson2.   

Abstract

Procyanidins have been extensively investigated for their potential health protective activities. However, the potential bioactivities of procyanidins are limited by their poor bioavailability. The majority of the ingested dose remains unabsorbed and reaches the colon where extensive microbial metabolism occurs. Most existing analytical methods measure either native compounds (catechins and procyanidins), or their microbial metabolites. The objectives of this study were to develop a high-throughput extraction and UPLC-MS/MS method for simultaneous measurement of both native procyanidins and their metabolites, facilitating high-throughput analysis of native and metabolite profiles in various regions of the colon. The present UPLC-MS/MS method facilitates simultaneous resolution and detection of authentic standards of 14 native catechin monomers and procyanidins, as well as 24 microbial metabolites. Detection and resolution of an additional 3 procyanidin dimers and 10 metabolites for which standards were not available was achieved. Elution and adequate resolution of both native compounds and metabolites were achieved within 10min. The intraday repeatability for native compounds was between 1.1 and 16.5%, and the interday repeatability for native compounds was between 2.2 and 25%. Intraday and interday repeatability for metabolites was between 0.6 and 24.1% and 1 and 23.9%, respectively. Observed lower limits of quantification for native compounds were ∼9-350fmol on-column, and for the microbial metabolites were ∼0.8-12,000fmol on-column. Observed lower limits of detection for native compounds were ∼4.5-190fmol on-column, and for metabolites were 0.304-6020fmol on-column. For native monomers and procyanidins, extraction recoveries ranged from 38 to 102%. Extraction recoveries for the 9 microbial metabolites tested ranged from 41 to 95%. Data from tissue analysis of rats gavaged with grape seed extract indicate fairly high accumulation of native compounds, primarily monomers and dimers, in the cecum and colon. Metabolite data indicate the progressive nature of microbial metabolism as the digesta moves through the lower GI tract. This method facilitates the high-throughput, sensitive, and simultaneous analysis of both native compounds and their microbial metabolites in biological samples and provides a more efficient means of extraction and analysis than previous methods.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colon; Grape seed extract; LC–MS; Metabolism; Microflora; Procyanidins

Mesh:

Substances:

Year:  2014        PMID: 24704909     DOI: 10.1016/j.jchromb.2014.03.011

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

1.  The Chemistry of Gut Microbial Metabolism of Polyphenols.

Authors:  Jan F Stevens; Claudia S Maier
Journal:  Phytochem Rev       Date:  2016-03-11       Impact factor: 5.374

2.  Effect of consuming a grape seed supplement with abundant phenolic compounds on the oxidative status of healthy human volunteers.

Authors:  Felix Grases; Rafel M Prieto; Rafel A Fernández-Cabot; Antonia Costa-Bauzá; Ana M Sánchez; Marin Prodanov
Journal:  Nutr J       Date:  2015-09-09       Impact factor: 3.271

3.  Olive and grape seed extract prevents post-traumatic osteoarthritis damages and exhibits in vitro anti IL-1β activities before and after oral consumption.

Authors:  Elsa Mével; Christophe Merceron; Claire Vinatier; Stéphanie Krisa; Tristan Richard; Martial Masson; Julie Lesoeur; Vincent Hivernaud; Olivier Gauthier; Jérôme Abadie; Geoffroy Nourissat; Xavier Houard; Yohann Wittrant; Nelly Urban; Laurent Beck; Jérôme Guicheux
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

4.  A Combined LC-MS Metabolomics- and 16S rRNA Sequencing Platform to Assess Interactions between Herbal Medicinal Products and Human Gut Bacteria in Vitro: a Pilot Study on Willow Bark Extract.

Authors:  Eva-Maria Pferschy-Wenzig; Kaisa Koskinen; Christine Moissl-Eichinger; Rudolf Bauer
Journal:  Front Pharmacol       Date:  2017-12-13       Impact factor: 5.810

5.  Evaluation of peanut skin and grape seed extracts to inhibit growth of foodborne pathogens.

Authors:  Jason Levy; Renee R Boyer; Andrew P Neilson; Sean F O'Keefe; Hyun Sik S Chu; Robert C Williams; Melanie R Dorenkott; Katheryn M Goodrich
Journal:  Food Sci Nutr       Date:  2017-08-31       Impact factor: 2.863

6.  The Donor-Dependent and Colon-Region-Dependent Metabolism of (+)-Catechin by Colonic Microbiota in the Simulator of the Human Intestinal Microbial Ecosystem.

Authors:  Qiqiong Li; Florence Van Herreweghen; Marjan De Mey; Geert Goeminne; Tom Van de Wiele
Journal:  Molecules       Date:  2021-12-23       Impact factor: 4.411

7.  Electroacupuncture modulates the intestinal microecology to improve intestinal motility in spinal cord injury rats.

Authors:  Jie Cheng; Weimin Li; Ying Wang; Qing Cao; Ying Ni; Wenyi Zhang; Jiabao Guo; Binglin Chen; Yaning Zang; Yi Zhu
Journal:  Microb Biotechnol       Date:  2021-11-19       Impact factor: 5.813

8.  Interspecies cross-feeding orchestrates carbon degradation in the rumen ecosystem.

Authors:  Lindsey M Solden; Adrian E Naas; Simon Roux; Rebecca A Daly; William B Collins; Carrie D Nicora; Sam O Purvine; David W Hoyt; Julia Schückel; Bodil Jørgensen; William Willats; Donald E Spalinger; Jeffrey L Firkins; Mary S Lipton; Matthew B Sullivan; Phillip B Pope; Kelly C Wrighton
Journal:  Nat Microbiol       Date:  2018-10-24       Impact factor: 17.745

9.  The effect of grape seed and green tea extracts on the pharmacokinetics of imatinib and its main metabolite, N-desmethyl imatinib, in rats.

Authors:  Ruba S Darweesh; Tamam El-Elimat; Aref Zayed; Tareq N Khamis; Wahby M Babaresh; Tawfiq Arafat; Ahmed H Al Sharie
Journal:  BMC Pharmacol Toxicol       Date:  2020-11-16       Impact factor: 2.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.